Management of decompensated liver cirrhosis in the intensive care unit;Management der dekompensierten Leberzirrhose auf der Intensivstation

Medizinische Klinik - Intensivmedizin und Notfallmedizin

Volumn 108, Issue 8, 2013, Pages 646-656

  Lerschmacher, O ^a   Koch, A ^a   Streetz, K ^a   Trautwein, C ^a   Tacke, F ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Ascites; Hemorrhage; Hepatic encephalopathy; Hepatorenal syndrome; Hypertension, portal

Indexed keywords

ARTICLE; BACTERIAL PERITONITIS; BLEEDING; DECOMPENSATED LIVER CIRRHOSIS; HEPATORENAL SYNDROME; HUMAN; INTENSIVE CARE UNIT; LIVER TRANSPLANTATION; MORTALITY; PROGNOSIS; RESPIRATORY FAILURE; ALGORITHM; DIFFERENTIAL DIAGNOSIS; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; LIVER CIRRHOSIS;

ALGORITHMS; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMANS; INTENSIVE CARE UNITS; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PROGNOSIS;

EID: 84891346227     PISSN: 21936218     EISSN: 21936226     Source Type: Journal    
DOI: 10.1007/s00063-013-0259-6     Document Type: Article

References (51)

1. Al-Khafaji A, Huang DT (2011) Critical care management of patients with end-stage liver disease. Crit Care Med 39: 1157-1166.
2. Anonymous (2010) EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 53: 397-417.
3. Banares R, Nevens F, Larsen FS et al (2013) Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology 57: 1153-1162.
4. Bass NM, Mullen KD, Sanyal A et al (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362: 1071-1081.
5. Biancofiore G, Auzinger G, Mandell S et al (2012) Liver cirrhosis in the medical critical care patient. Minerva Anestesiol 78: 693-703.
6. Conn HO, Lieberthal MM (1979) The hepatic coma syndromes and lactulose. Williams & Wilkins, Baltimore.
7. Das V, Boelle PY, Galbois A et al (2010) Cirrhotic patients in the medical intensive care unit: early prognosis and long-term survival. Crit Care Med 38: 2108-2116.
8. Dellinger RP, Levy MM, Rhodes A et al (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41: 580-637.
9. Fritz JS, Fallon MB, Kawut SM (2013) Pulmonary vascular complications of liver disease. Am J Respir Crit Care Med 187: 133-143.
10. Garcia-Pagan JC, Caca K, Bureau C et al (2010) Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 362: 2370-2379.
11. Garcia-Tsao G (2004) Spontaneous bacterial peritonitis: a historical perspective. J Hepatol 41: 522-527.
12. Garcia-Tsao G, Bosch J (2010) Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 362: 823-832.
13. Gerbes AL, Gulberg V, Sauerbruch T et al (2011) German S3-guideline "ascites, spontaneous bacterial peritonitis, hepatorenal syndrome". Z Gastroenterol 49: 749-779.
14. Gustot T, Durand F, Lebrec D et al (2009) Severe sepsis in cirrhosis. Hepatology 50: 2022-2033.
15. Hasper D, Jorres A (2011) New insights into the management of hepato-renal syndrome. Liver Int 31(Suppl 3): 27-30.
16. Hoeper MM, Krowka MJ, Strassburg CP (2004) Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 363: 1461-1468.
17. Jensen DM (2002) Endoscopic screening for varices in cirrhosis: findings, implications, and outcomes. Gastroenterology 122: 1620-1630.
18. Jiang Q, Jiang XH, Zheng MH et al (2008) Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis. Eur J Gastroenterol Hepatol 20: 1064-1070.
19. Koch A, Buendgens L, Duckers H et al (2013) Gastrointestinal bleeding in liver cirrhosis at the ICU. Z Gastroenterol 51: 19-25.
20. Kribben A, Gerken G, Haag S et al (2012) Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure. Gastroenterology 142: 782-789 e3.
21. Laleman W (2009) Hemodynamic effects of albumin dialysis in patients with liver failure: for better or for worse? Ther Apher Dial 13: 384-392.
22. Leber B, Spindelboeck W, Stadlbauer V (2012) Infectious complications of acute and chronic liver disease. Semin Respir Crit Care Med 33: 80-95.
23. Levesque E, Hoti E, Azoulay D et al (2012) Prospective evaluation of the prognostic scores for cirrhotic patients admitted to an intensive care unit. J Hepatol 56: 95-102.
24. Manns MP (2013) Liver cirrhosis, transplantation and organ shortage. Dtsch Arztebl Int 110: 83-84.
25. Marcelino PA, Marum SM, Fernandes AP et al (2009) Routine transthoracic echocardiography in a general Intensive Care Unit: an 18 month survey in 704 patients. Eur J Intern Med 20: e37-e42.
26. Moller S, Bernardi M (2013) Interactions of the heart and the liver. Eur Heart J.
27. Moller S, Henriksen JH (2010) Cirrhotic cardiomyopathy. J Hepatol 53: 179-190.
28. Plauth M (2013) Nutrition and liver failure. Med Klin Intensivmed Notfmed 108: 391-395.
29. Plauth M, Cabre E, Campillo B et al (2009) ESPEN guidelines on parenteral nutrition: hepatology. Clin Nutr 28: 436-444.
30. Plauth M, Cabre E, Riggio O et al (2006) ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr 25: 285-294.
31. Prakash R, Mullen KD (2010) Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol 7: 515-525.
32. Prasad S, Dhiman RK, Duseja A et al (2007) Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45: 549-559.
33. Rifai K, Bahr MJ, Schneider A et al (2003) New devices in liver replacement therapy. Med Klin (Munich) 98: 750-753.
34. Rodriguez-Roisin R, Krowka MJ (2008) Hepatopulmonary syndrome-a liver-induced lung vascular disorder. N Engl J Med 358: 2378-2387.
35. Rodriguez-Roisin R, Krowka MJ, Herve P et al (2004) Pulmonary-Hepatic vascular Disorders (PHD). Eur Respir J 24: 861-880.
36. Runyon BA (2009) Management of adult patients with ascites due to cirrhosis: an update. Hepatology 49: 2087-2107.
37. Sado D, Greaves K (2011) Myocardial perfusion echocardiography: a novel use in the diagnosis of sepsis-induced left ventricular systolic impairment on the intensive care unit. Eur J Echocardiogr 12: 81-84.
38. Sagi SV, Mittal S, Kasturi KS et al (2010) Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol 25: 880-885.
39. Savale L, O'Callaghan DS, Magnier R et al (2011) Current management approaches to portopulmonary hypertension. Int J Clin Pract Suppl 11-18.
40. Sharma BC, Sharma P, Agrawal A et al (2009) Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. Gastroenterology 137: 885-891, 891 e881.
41. Slack A, Yeoman A, Wendon J (2010) Renal dysfunction in chronic liver disease. Crit Care 14: 214.
42. Sort P, Navasa M, Arroyo V et al (1999) Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 341: 403-409.
43. Tacke F, Fiedler K, Trautwein C (2007) A simple clinical score predicts high risk for upper gastrointestinal hemorrhages from varices in patients with chronic liver disease. Scand J Gastroenterol 42: 374-382.
44. Vaid A, Chweich H, Balk EM et al (2012) Molecular adsorbent recirculating system as artificial support therapy for liver failure: a meta-analysis. ASAIO J 58: 51-59.
45. Warrillow SJ (2010) Predictions and outcomes for the critically ill patient with cirrhosis: is it time to settle on the SOFA and let jaundiced views on outcome MELD away? Crit Care Med 38: 2259-2260.
46. Wiegand J, Berg T (2013) The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis. Dtsch Arztebl Int 110: 85-91.
47. Wittenburg H, Tennert U, Berg T (2011) Complications of liver cirrhosis. Internist 52: 1061-1070; quiz 1071-1072.
48. Wong F (2011) Renal diseases and the liver. Clin Liver Dis 15: 39-53.
49. Wong F, Nadim MK, Kellum JA et al (2011) Working party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut 60: 702-709.
50. Zimmermann HW, Koch A, Seidler S et al (2012) Circulating soluble urokinase plasminogen activator is elevated in patients with chronic liver disease, discriminates stage and aetiology of cirrhosis and predicts prognosis. Liver Int 32: 500-509.
51. Zimmermann HW, Reuken PA, Koch A et al (2013) Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short-term mortality. J Intern Med 274: 86-100.